Victoria Gray spent 34 years battling the debilitating pain of sickle cell disease. Then she volunteered to be the world's first "prototype" for a CRISPR therapy, based on technology invented at UC ...
A new CRISPR breakthrough shows scientists can turn genes back on without cutting DNA, by removing chemical tags that act ...
Researchers have unveiled a way to flip genes back on without slicing into the genome, a shift that could make CRISPR far ...
How does the CRISPR Down Syndrome breakthrough work to remove the extra chromosome 21? We are closer than ever to a world where a genetic condition affecting one in every 700 babies could be addressed ...
St. Georges Technical High School students using CRISPR in a Box. On Friday, the US Food and Drug Administration approved a sickle cell disease drug called Casgevy, co-developed by Vertex ...
One of the most well-known versions of the gene-editing tool CRISPR may not work in a large proportion of the population, according to recent research out of Stanford University in California. CRISPR, ...
Developing a gene therapy typically takes years, but when Baby KJ was diagnosed with a deadly genetic condition, scientists had only months. What followed was a successful collaboration among ...
Prof KC Bansal, former director of the ICAR–National Bureau of Plant Genetic Resources, is a leading plant biotechnologist specialising in genetic engineering and CRISPR-based genome editing. He is ...
Stay on top of what’s happening in the Bay Area with essential Bay Area news stories, sent to your inbox every weekday. The Bay Bay Area-raised host Ericka Cruz Guevarra brings you context and ...
NASA astronaut Nick Hague runs an analysis with the miniPCR hardware for Genes in Space-6 during Expedition 59. This experiment explored how space radiation damages DNA and how cells repair that ...
When you buy through links on our articles, Future and its syndication partners may earn a commission. Credit: DrAfter123 via Getty Images Since CRISPR was first conceived as a gene-editing tool in ...
There's still a lot of uncertainty regarding CRISPR right now. For one thing, lawyers are waiting new developments in the ongoing dispute between the Broad Institute and the University of California.